Tessera Therapeutics
Shuang Tian is a Senior Research Associate at Tessera Therapeutics, a position held since October 2020, following a tenure as Research Associate II. Prior experience includes serving as a Graduate Research Assistant and Teaching Assistant at Tufts University from September 2018 to October 2020 while completing a Master’s degree in Pharmacology and Drug Development. Shuang Tian also gained experience as an intern at Beijing Tongren Hospital and Beijing Tiantan Hospital between 2016 and 2018. The educational background includes a Master's degree from Tufts University (2018-2020) and a Bachelor's degree in Medicine from Capital Medical University (2013-2018).
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.